Monoferric denied as not medically necessary by Aetna?

Aetna's specific coverage criteria for monoferric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Monoferric on Medical-Necessity Grounds

Monoferric (ferric derisomaltose) is an intravenous iron replacement therapy. Aetna, like most large commercial insurers, applies a medical-necessity standard that requires documented evidence that oral iron has failed, is contraindicated, or cannot be tolerated, and that the underlying condition producing iron deficiency has been properly diagnosed and is of sufficient clinical severity. Denials on this basis are common when the chart lacks explicit documentation of those elements — not because IV iron is inappropriate, but because the record did not speak clearly enough to satisfy the reviewer.

## Why This Denial Is Appealable

A medical-necessity denial is one of the most routinely overturned denial types on appeal. Aetna's own clinical policy must align with accepted standards of care, and IV iron formulations like Monoferric have well-established roles in the treatment of iron-deficiency anemia across multiple clinical contexts. If your prescriber's records show the clinical rationale, the denial can be challenged directly.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): You have the right to a full-and-fair internal review. Submit within the timeframe on your denial letter (typically 180 days for ERISA plans).
• External review (ACA §2719): After exhausting internal appeal, or if Aetna does not resolve within statutory timeframes, you may request an independent external review. Federal law provides approximately a 4-month window from the final internal denial. An independent organization — not Aetna — then makes the binding decision.
• Expedited review: If delay would seriously jeopardize your health, you may request expedited internal and external review simultaneously, with a response required within 72 hours.

## Documentation to Gather

1. Diagnosis confirmation — lab results and clinical notes confirming iron-deficiency anemia and its underlying cause. 2. Prior treatment history — a dated record of oral iron trials, including why they failed (intolerance, malabsorption, insufficient response) or why they are contraindicated. 3. Clinical severity — chart notes quantifying the severity of anemia and any functional impact (fatigue, dyspnea, impaired quality of life). 4. Prescriber medical-necessity letter — a signed statement from your physician explaining why IV iron is required now and why Monoferric specifically is appropriate. 5. Applicable guideline reference — ask your prescriber to cite the relevant professional society guidelines (e.g., applicable hematology or gastroenterology society guidance) without inventing specific numbers.

## Criteria-Mapping Structure

Obtain Aetna's published clinical policy for IV iron from their provider portal or by request. List each stated requirement in column one. In column two, document the exact chart fact that satisfies it — date, lab value, clinician note. A structured table submitted with your appeal letter makes it easy for the reviewer to approve without further questions. Do not let a documentation gap do the work of a clinical disagreement.